维普期刊资源整合服务平台（V6.5）

529篇 您的检索式：作者名="DEMETRI GD"

选中清除导出查看参考文献查看引证文献引用追踪共27页首页上一页第1页下一页末页 /27 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅲ randomized,intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase:S0033显示文摘	Blanke CD Rankin C Demetri GD		0，，04：	3
2	Long-term results from a randomized phase Ⅱ trial of standard-versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT显示文摘	Blanke CD Demetri GD yon Mehren M		0，，04：	3
3	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD		0，，：	2
4	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD		0，，07：	2
5	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	DEMETRI GD VON MEHREN M BLANKE CD	2002	N Engl J Med2002，347，：	1
6	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib:A randomised controlled trial显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，：	1
7	Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal turnout after failure of imatinib : A randomised controlled trial 显示文摘	Demetri GD van Oosterom AT Garrett CR	2006	Lancet2006，368，：	1
8	Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor显示文摘	Bauer S Yu LK Demetri GD	2006	Cancer Res2006，66，18：	1
9	Phase Ill randomized, in- tergroup trial assessing imatinibmesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromahumors express- ing the kit receptor tyrosine kinase: S0033 显示文摘	Blanke CD Rankin C Demetri GD	2008	J Clin Oncol2008，26，4：	1
10	Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘	Henderson IC Berry DA Demetri GD	2003	J Clin Oncol2003，21，6：	1
11	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors 显示文摘	Demetri GD von Mehren M Blanke CD	2002	N Engl J Med2002，347，：	1
12	Long-term re- sults from a randomized phase II trial of standard versus high- er-dose imatinib rnesylate for patients with unresectable or me- tastatic gastrointestinal stromal tumors expressing NIT显示文摘	Blanke CD Demetri GD yon Mehren M	2008	Clin Oncol2008，26，4：	1
13	NCCN task force report:management of patients with gastrointestinal stromal tumor(GIST)--update of the NCCN clinical practice guidelines显示文摘	Demetri GD Blanke CD	2007	J Natl Comp Cancer Network2007，52，：	1
14	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors 显示文摘	Demetri GD von Mehren M Blanke CD	2002	N Engl J Med2002，347，7：	1
15	Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)显示文摘	Heinrich MC McArthur GA Demetri GD		0，，07：	1
16	Improved outcomes from adding sequential paclitaxel but not from eslating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer 显示文摘	Henderson IC Berry D Demetri GD	2003	J Clin Oncol2003，21，6：	1
17	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumor显示文摘	Demetri GD Von Mehren M Blanke CD	2002	N Engl Med2002，347，7：	1
18	Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors显示文摘	Demetri GD von Mehren M Blanke CD		0，，07：	1
19	NCCN Task Force report:update on the management of patients with gastrointestinal stromal tumors 显示文摘	Demetri GD von Mehren M Antonescu GR	2010	J Natl Compr Canc Netw2010，82，：	1
20	Improved outcomes from adding sequential paclixaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer显示文摘	Henderson IC Berry DA Demetri GD	2003	J Clin Oncol2003，21，8：	1

返回顶部每页显示：

共27页首页上一页第1页下一页末页 /27 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示